An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee
Clinical trial NCT04731675 · COMPLETED
Trial details
- NCT number
- NCT04731675
- Sponsor
- AmMax Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-25
- Primary completion
- 2022-05-05
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.